The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TOPOLOGY: A phase II study to evaluate the efficacy and toxicities of PLX038, in patients with locally advanced or metastatic triple-negative breast cancer.
 
Luc Cabel
No Relationships to Disclose
 
Delphine Loirat
Honoraria - AstraZeneca; Gilead Sciences; Gilead Sciences; Lilly; MSD
Consulting or Advisory Role - 4D Pharma; AstraZeneca; Gilead Sciences; Immunomedics; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; MSD; Pfizer; Roche
 
Jerome Martin Babau
No Relationships to Disclose
 
Diana Bello
Travel, Accommodations, Expenses - daiichi sankyo; Lilly
 
Jean-Yves Pierga
Honoraria - Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); Novartis (Inst)
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Europe GmbH; Eisai Europe (Inst); Exact Sciences; Gilead Sciences; Lilly; Menarini Group; MSD Oncology; MSD Oncology (Inst); Novartis; Pfizer; Roche/Genentech; Roche/Genentech (Inst); Seagen; Veracyte
Research Funding - Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences; Pfizer
 
Florence Lerebours
Consulting or Advisory Role - AstraZeneca; Eisai; Gilead Sciences; Lilly; Menarini; Novartis; Roche; Seagen
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
 
Cyrine Ezzili
No Relationships to Disclose
 
Frederique Berger
No Relationships to Disclose
 
Francois Clement Bidard
Consulting or Advisory Role - AstraZeneca; Caris Life Sciences; Daiichi-Sankyo; Exact Sciences; GE Healthcare; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Roche; SAGA Diagnostics
Speakers' Bureau - AstraZeneca; Daiichi-Sankyo; Lilly; Menarini Group; Novartis; Pfizer
Research Funding - GE Healthcare (Inst); Menarini Silicon Biosystems (Inst); Merck KGaA (Inst); MSD (Inst); Novartis (Inst); Personalis (Inst); Pfizer (Inst); Prolynx (Inst); SAGA Diagnostics (Inst)
Patents, Royalties, Other Intellectual Property - ESR1 & MSI detection techniques (patents) (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi-Sankyo; Novartis; Pfizer; Roche